8-K
filed February 24, 2026, 6:59 PM ET
ticker BMRC
CIK 0001403475
other material
confidence high
sentiment negative
materiality 0.75
Bank of Marin restates financials due to deposit misclassification; net income unchanged
Bank of Marin Bancorp
- Board concluded previously issued financials for FY2023, FY2024, and Q1-Q3 2025 should not be relied upon.
- Errors reclassified reciprocal deposits: for FY2025 year-end, $237.8M moved from non-interest to interest-bearing deposits.
- Net income and EPS unchanged for all affected periods; adjustments affect NIM, cost of deposits, efficiency ratio.
- Preliminary adjustments show FY2025 net interest margin (reported) drops 12bps to 2.92%; cost of deposits rises 13bps to 1.39%.
- Management is evaluating internal control over financial reporting for potential material weakness as of Dec 31, 2025.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001403475-26-000011
- form_type
- 8-K
- ticker
- BMRC
- cik
- 0001403475
- company_name
- Bank of Marin Bancorp
- filed_at
- 2026-02-24T23:59:59+00:00
- discovered_at
- 2026-05-14T18:02:34.998080+00:00
- generated_at
- 2026-05-16T00:45:53.610799+00:00
- sec_items
- ["4.02"]
- event_type
- other_material
- sentiment
- negative
- materiality_score
- 0.75
- calibrated_materiality_score
- 0.75
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001403475-26-000011
- json_url
- https://secwatch.observer/filing/0001403475-26-000011.json
- markdown_url
- https://secwatch.observer/filing/0001403475-26-000011.md
- text_url
- https://secwatch.observer/filing/0001403475-26-000011.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1403475/000140347526000011/0001403475-26-000011-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1403475/000140347526000011/bmrc-20260223.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
RITE
MineralRite restates financials, cuts asset carrying value from $432M to $246M
MINERALRITE Corp
May 27, 2026, 4:02 PM ET
other_material
Items 4.02, 7.01, 8.01, 9.01
same fact type: auditor_change
same SEC item: 4.02
same event type: other_material
similar materiality
This filing
(a) Restatement of Historical Financial Results On February 23, 2026, the Board of Directors (the “Board”) of Bank of Marin Bancorp (the “Company”), based on the recommendation of, and after consultation with, the Board’s Audit Committee, the Company’s management and the Company’s independent registered public accounting firm, Baker Tilly, concluded that the Company’s previously issued audited consolidated financial statements as of and for the years ended December 31, 2024 and 2023 and the unaudited financial statements as of and for the interim periods ended September 30, 2025, June 30, 2025, March 31, 2025, September 30, 2024, June 30, 2024, and March 31, 2024 (the “Affected Periods”) included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024 and the Company’s Quarterly Reports on Form 10-Q for each of the applicable interim periods (the financial statem
Comparable filing
management determined that certain previously issued financial statements contained in the Company’s previously filed Annual Report on Form 10 for the fiscal year ended December 31, 2025, and Quarterly Report on Form 10-Q for the quarter ended March 31, 2026, should no longer be relied upon.
Filing page
SEC filing
NMTC
NeuroOne restates Q1 FY2026 results due to revenue recognition error; reaffirms FY2026 guidance
NEUROONE MEDICAL TECHNOLOGIES Corp
May 22, 2026, 4:30 PM ET
other_material
Items 4.02, 7.01, 9.01
same fact type: auditor_change
same SEC item: 4.02
same event type: other_material
similar materiality
This filing
(a) Restatement of Historical Financial Results On February 23, 2026, the Board of Directors (the “Board”) of Bank of Marin Bancorp (the “Company”), based on the recommendation of, and after consultation with, the Board’s Audit Committee, the Company’s management and the Company’s independent registered public accounting firm, Baker Tilly, concluded that the Company’s previously issued audited consolidated financial statements as of and for the years ended December 31, 2024 and 2023 and the unaudited financial statements as of and for the interim periods ended September 30, 2025, June 30, 2025, March 31, 2025, September 30, 2024, June 30, 2024, and March 31, 2024 (the “Affected Periods”) included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024 and the Company’s Quarterly Reports on Form 10-Q for each of the applicable interim periods (the financial statem
Comparable filing
On May 21, 2026, the Audit Committee (the “Audit Committee”) of the Board of Directors of NeuroOne Medical Technologies Corporation (the “Company”), after discussion with management, determined that the Company’s previously issued interim financial statements included in the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2026, filed on May 12, 2026 (the “Previous Filing”), should no longer be relied upon and should be restated because of accounting errors relating to revenue recognition.
Filing page
SEC filing
ZONE
CleanCore Solutions restates Q3 2026 financials; 70M Dogecoin transfer error
CleanCore Solutions, Inc.
May 18, 2026, 4:30 PM ET
other_material
Items 4.02
same fact type: auditor_change
same SEC item: 4.02
same event type: other_material
similar materiality
This filing
(a) Restatement of Historical Financial Results On February 23, 2026, the Board of Directors (the “Board”) of Bank of Marin Bancorp (the “Company”), based on the recommendation of, and after consultation with, the Board’s Audit Committee, the Company’s management and the Company’s independent registered public accounting firm, Baker Tilly, concluded that the Company’s previously issued audited consolidated financial statements as of and for the years ended December 31, 2024 and 2023 and the unaudited financial statements as of and for the interim periods ended September 30, 2025, June 30, 2025, March 31, 2025, September 30, 2024, June 30, 2024, and March 31, 2024 (the “Affected Periods”) included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024 and the Company’s Quarterly Reports on Form 10-Q for each of the applicable interim periods (the financial statem
Comparable filing
concluded that the Company’s previously issued unaudited condensed consolidated financial statements included in the Company’s Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2026, filed with the Securities and Exchange Commission (the “SEC”) on May 11, 2026 (the “Q3 2026 10-Q”), should no longer be relied upon and should be restated.
Filing page
SEC filing
CGC
Canopy Growth restates FY2024-2025 financials due to warrant classification error; Q4/FY2026 results delayed to June 15
Canopy Growth Corp
May 15, 2026, 5:06 PM ET
other_material
Items 4.02, 7.01, 9.01
same fact type: auditor_change
same SEC item: 4.02
same event type: other_material
similar materiality
This filing
(a) Restatement of Historical Financial Results On February 23, 2026, the Board of Directors (the “Board”) of Bank of Marin Bancorp (the “Company”), based on the recommendation of, and after consultation with, the Board’s Audit Committee, the Company’s management and the Company’s independent registered public accounting firm, Baker Tilly, concluded that the Company’s previously issued audited consolidated financial statements as of and for the years ended December 31, 2024 and 2023 and the unaudited financial statements as of and for the interim periods ended September 30, 2025, June 30, 2025, March 31, 2025, September 30, 2024, June 30, 2024, and March 31, 2024 (the “Affected Periods”) included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024 and the Company’s Quarterly Reports on Form 10-Q for each of the applicable interim periods (the financial statem
Comparable filing
the audit committee of the board of directors of the Company (the “Audit Committee”) was made aware of and, after discussion with senior management of the Company, concluded that the Company’s previously issued (i) audited consolidated financial statements for the fiscal year ended March 31, 2024, included in the Company’s Annual Report on Form 10-K for such fiscal year (the “2024 10-K”), (ii) audited consolidated financial statements for the fiscal year ended March 31, 2025, included in the Company’s Annual Report on Form 10-K for such fiscal year (the “2025 10-K”) and (iii) unaudited consolidated financial statements for the quarterly periods ended September 30, 2023, December 31, 2023, June 30, 2024, September 30, 2024, December 31, 2024, June 30, 2025, September 30, 2025, and December 31, 2025, included in the Company’s Quarterly Reports on Form 10-Q for such quarterly periods (collectively, the “Prior Financial Statements”), should no longer be relied upon
Filing page
SEC filing
CETY
Clean Energy Technologies restates financials for 2022-2025 due to accounting errors
Clean Energy Technologies, Inc.
May 7, 2026, 7:59 PM ET
other_material
Items 4.02
same fact type: auditor_change
same SEC item: 4.02
same event type: other_material
similar materiality
This filing
(a) Restatement of Historical Financial Results On February 23, 2026, the Board of Directors (the “Board”) of Bank of Marin Bancorp (the “Company”), based on the recommendation of, and after consultation with, the Board’s Audit Committee, the Company’s management and the Company’s independent registered public accounting firm, Baker Tilly, concluded that the Company’s previously issued audited consolidated financial statements as of and for the years ended December 31, 2024 and 2023 and the unaudited financial statements as of and for the interim periods ended September 30, 2025, June 30, 2025, March 31, 2025, September 30, 2024, June 30, 2024, and March 31, 2024 (the “Affected Periods”) included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024 and the Company’s Quarterly Reports on Form 10-Q for each of the applicable interim periods (the financial statem
Comparable filing
irm, TAAD, LLP. SIGNATURES Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
Filing page
SEC filing
DCO
Ducommun restates 2024-2025 financials; net income overstated $9.8M in 2024, $3.4M in 2025
DUCOMMUN INC /DE/
May 1, 2026, 7:59 PM ET
other_material
Items 4.02
same fact type: auditor_change
same SEC item: 4.02
same event type: other_material
similar materiality
This filing
(a) Restatement of Historical Financial Results On February 23, 2026, the Board of Directors (the “Board”) of Bank of Marin Bancorp (the “Company”), based on the recommendation of, and after consultation with, the Board’s Audit Committee, the Company’s management and the Company’s independent registered public accounting firm, Baker Tilly, concluded that the Company’s previously issued audited consolidated financial statements as of and for the years ended December 31, 2024 and 2023 and the unaudited financial statements as of and for the interim periods ended September 30, 2025, June 30, 2025, March 31, 2025, September 30, 2024, June 30, 2024, and March 31, 2024 (the “Affected Periods”) included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024 and the Company’s Quarterly Reports on Form 10-Q for each of the applicable interim periods (the financial statem
Comparable filing
Due to the identification of this Error, on May 1, 2026, management concluded that the following previously issued financial statements of the Company (and related earnings releases, press releases, shareholder communications, investor presentations or other materials describing relevant portions of such financial statements) should no longer be relied upon
Filing page
SEC filing
LRHC
La Rosa to restate FY2024 & interim results; revenue overstated $10.8M due to agent/principal error
La Rosa Holdings Corp.
April 24, 2026, 7:59 PM ET
other_material
Items 4.02
same fact type: auditor_change
same SEC item: 4.02
same event type: other_material
similar materiality
This filing
(a) Restatement of Historical Financial Results On February 23, 2026, the Board of Directors (the “Board”) of Bank of Marin Bancorp (the “Company”), based on the recommendation of, and after consultation with, the Board’s Audit Committee, the Company’s management and the Company’s independent registered public accounting firm, Baker Tilly, concluded that the Company’s previously issued audited consolidated financial statements as of and for the years ended December 31, 2024 and 2023 and the unaudited financial statements as of and for the interim periods ended September 30, 2025, June 30, 2025, March 31, 2025, September 30, 2024, June 30, 2024, and March 31, 2024 (the “Affected Periods”) included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024 and the Company’s Quarterly Reports on Form 10-Q for each of the applicable interim periods (the financial statem
Comparable filing
n this Current Report on Form 8-K with CBIZ CPAs P.C., the Company’s independent registered public accounting firm. 1 SIGNATURES Pursuant to the requirements of the Securities
Filing page
SEC filing
PREAXIA HEALTH CARE PAYMENT SYSTEMS INC.
PreAxia restates Aug 31, 2025 financials; stock award errors, material weakness
PREAXIA HEALTH CARE PAYMENT SYSTEMS INC.
April 21, 2026, 7:59 PM ET
other_material
Items 4.02, 9.01
same fact type: auditor_change
same SEC item: 4.02
same event type: other_material
similar materiality
This filing
(a) Restatement of Historical Financial Results On February 23, 2026, the Board of Directors (the “Board”) of Bank of Marin Bancorp (the “Company”), based on the recommendation of, and after consultation with, the Board’s Audit Committee, the Company’s management and the Company’s independent registered public accounting firm, Baker Tilly, concluded that the Company’s previously issued audited consolidated financial statements as of and for the years ended December 31, 2024 and 2023 and the unaudited financial statements as of and for the interim periods ended September 30, 2025, June 30, 2025, March 31, 2025, September 30, 2024, June 30, 2024, and March 31, 2024 (the “Affected Periods”) included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024 and the Company’s Quarterly Reports on Form 10-Q for each of the applicable interim periods (the financial statem
Comparable filing
On April 9, 2026, the management of PreAxia Health care Payment Systems Inc., a Nevada corporation (the “Company”), identified material errors in the previously released financial statements for the three months ended August 31, 2025 (the “Non-Reliance Period”) and concluded that such financial statements should no longer be relied upon.
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.